An investigation into the gap in clinical trial enrollment rates for Caucasians and African Americans in the USA has confirmed the presence of a significant level of distrust on the part of the latter group. Researchers at Johns Hopkins University in Baltimore, Maryland, found blacks were 40% less likely to be willing to register for what was in fact a mock clinical study.
The survey was conducted at 13 medical facilities in Maryland, with 717 patients, about one third of whom were black. While a quarter of whites said they believed physicians would use experimental drugs on patients without their consent, 58% of African Americans believed the need for their consent would be ignored.
Although the gap in patient trust across ethnic lines was less striking in some other survey questions, 25% and 28%, respectively, of African Americans said they thought their own doctor would enroll them in a study that might harm them or would willingly expose patients to unnecessary risks. The equivalent levels of distrust among Caucasian patients were 15% and 22%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze